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Abstract
In this study, we consider the problem of variable selection and estimation in
high-dimensional linear regression models when the complete data are not accessi-
ble, but only certain marginal information or summary statistics are available. This
problem is motivated from the Genome-wide association studies (GWAS) that have
been widely used to identify risk variants underlying complex human traits/diseases.
With a large number of completed GWAS, statistical methods using summary
statistics become more and more important because of restricted accessibility to
individual-level data sets. Theoretically guaranteed methods are highly demand-
ing to advance the statistical inference with a large amount of available marginal
information. Here we propose an `1 penalized approach, REMI, to estimate high
dimensional regression coefficients with marginal information and external reference
samples. We establish an upper bound on the error of the REMI estimator, which
has the same order as that of the minimax error bound of Lasso with complete
individual-level data. In particular, when marginal information is obtained from a
large number of samples together with a small number of reference samples, REMI
yields good estimation and prediction results, and outperforms the Lasso because the
sample size of accessible individual-level data can be limited. Through simulation
studies and real data analysis of the NFBC1966 GWAS data set, we demonstrate
that REMI can be widely applicable. The developed R package and the codes to re-
produce all the results are available at https://github.com/gordonliu810822/REMI
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1 Introduction
High dimensional regression has been widely applied in various fields, such as medicine,
biology, finance and marketing [14]. Consider the linear regression model that relates a
response variable Y to a vector of p predictors X = (X1, . . . , Xp)
T :
Y =
p∑
j=1
Xjβ
∗
j + , (1)
where β∗ = (β∗1 , . . . , β
∗
p)
T is the vector of regression coefficients and  is the random error
term with mean zero and noise level σ2 . In most applications, the data set is comprised of
an n×p matrix X for variables in X and a vector y = (y1, . . . , yn)T for response Y collected
from n individuals. Given the individual-level data {X,y}, there exist convex [31, 6]
and nonconvex [10, 44] penalized methods for estimating β∗ with theoretical guarantee
[47, 23, 45, 2, 46], just name a few. Also see the monographs [4, 15] and the references
therein.
Motivated from the applications in human genetics, we consider the problem of es-
timating β∗ when the individual-level data {X,y} is not accessible but the marginal
information is available, such as XTj y and X
T
j Xj, j = 1, . . . , p, where Xj is the j-th
column of X. For this reason, we refer to our problem formulation as ”regression with
marginal information” (REMI). To make our formulation feasible, we also assume that
information of the covariance structure of variables in X can be estimated via a reference
panel data set in the form of an nr×p data matrix Xr, where nr is the number of samples
from the reference panel and nr  p. A natural question arises: Without accessing the
individual-level data, can we use marginal information together with the reference data
Xr to estimate β
∗, assuming observations in Xr and X are from the same distribution?
In particular, our problem arises in genome-wide association studies (GWAS), which
have been conducted over the past decade to study the genetic basis of human complex
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phenotypes, including both quantitative traits and complex diseases [16, 39, 38]. As of
April, 2018, more than 59,000 unique phenotype-variant (typically Single Nucleotide Poly-
morphism, or SNP in short) associations have been reported in about 3,300 publications
of GWAS (see the GWAS Catalog database https://www.ebi.ac.uk/gwas/). An im-
portant lesson from GWAS [42, 36, 38] is that complex phenotypes are highly polygenic,
that is, they are often affected by many genetic variants with small effects. Well-known
examples include human height [40], psychiatric disorders [13], as well as diabetes [12].
Due to the polygenicity, variants with small effects largely remain undiscovered yet and
large sample sizes are required in exploring genetic architectures of complex phenotypes.
Researchers world-wide are forming large genomic consortia, such as the Genetic Inves-
tigation of ANthropometric Traits (GIANT) Consortium and the psychiatric genomic
consortium (PGC), to maximize sample size, aiming at a deeper understanding of the
genetic architecture of complex phenotypes.
Although much efforts have been made for data sharing, it is still very difficult for a
research group to fully access the individual-level genotype data available in a consortium.
For example, a core research group from the GAINT consortium reported that they can
only access genotype data from about 44,000 individuals [41] while the total sample size
is more than 250,000 for the consortium [40]. There are several reasons for the restricted
access to the individual-level data. First, privacy protection is always a big concern in
sharing individual-level genotype data. Second, it is often time-consuming to achieve an
agreement on data-sharing among different research groups. Third, many practical issues
arise in data transportation and storage. In contrast, summary statistics from GWAS
are widely available through many public gateways [24], e.g., the download session at the
GWAS Catalog https://www.ebi.ac.uk/gwas/downloads/summary-statistics. Be-
cause these summary statistics (e.g., estimated effect sizes, standard errors, and z-values)
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are often generated by simple linear regression analysis, summary statistics are essentially
marginal information.
To meet the great demand of data analysis in GWAS, various statistical methods have
been proposed to utilize marginal information. Using a few hundreds of human genome
data from the 1000 Genome Project as a reference panel, information on the correlation
structure of genetic variants (typically using “linkage disequilibrium” in genetics, or LD
for short) becomes available. This allows these methods to bypass the individual-level
data but only use marginal information. Here we roughly divide these methods into
three categories: (a) Methods for heritability estimation. Heritability of a phenotype
quantifies the relative importance of genetics and environment to the phenotype [37].
When individual-level data is accessible, linear mixed model (LMM)-based approaches
(e.g., GCTA [42, 43]) are widely used for heritability estimation [22]. In the absence of
individual-level data, Bulik et al. [5] first introduced the LD score regression, named
LDScore, for heritability estimation only using summary statistics and the reference data
from the 1000 Genome Project. Based on the minimal norm quadratic unbiased estimation
criteria, Zhou [48] proposed a novel method of moments, MQS, for variance component
estimation with summary statistics. (b) Methods for association mapping. Heritability
estimation provides a global measure which quantifies the overall contribution from ge-
netic factors while association mapping is to localize genetic variants associated with a
given phenotype. Recently, a few statistical methods have been proposed for association
mapping based on summary statistics, including FGWAS [26], PAINTOR [21], CAVIAR
[18], and CAVIARBF [7]. Although these methods are very useful for performing associa-
tion mapping on summary statistics, they still have their limitations. On one hand, they
adopted some ad-hoc ways to reduce computational cost. For example, to avoid a combi-
natorial search, FGWAS assumes that there is only one causal signal in an LD block and
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PAINTOR searches no more than two causal variants in its default setting. On the other
hand, statistical analysis is oversimplified to overcome estimation difficulties. For exam-
ple, the non-centrality parameter in PAINTOR and the variance components in CAVIAR
and CAVIARBF are pre-fixed rather than adaptively estimated from data. (c) Methods
for effect size estimation and risk prediction. Recently, Vilhja´lmsson et al. [35] proposed
a Bayesian method, LDpred, for effect size estimation and risk prediction by accounting
for LD. Along this line, Hu et al. [19] further introduced AnnoPred to improve LDpred
by incorporating functional information in human genome. However, neither LDpred
or AnnonPred should be considered as a marginal-information-based method because it
requires individual-level data as validation data for its parameter tuning.
Although the existing statistical methods have shown a good empirical performance in
GWAS data analysis, there are a number of open questions on REMI. First, the sample size
of the reference panel is often very small. For example, there are only about 370 samples
from the 1000 Genome Project that can be used as reference for analyzing GWAS data in
European ancestry. It remains unclear why such a small sample size is often good enough
for exploring the correlation structure of a large number of variables (i.e., SNPs). Second,
the theoretical properties of the existing methods for effect size estimation and prediction
error are not clear. Third, the sampling-based algorithms are often time-consuming as
they need to run thousands of Markov Chain Monte Carlo (MCMC) iterations [49]. In
this paper, we propose a unified framework to address the above open questions. The
rest of this paper is organized as follows: In Section 2, we introduce our REMI model
and discuss REMI in GWAS. In Section 3, we present an efficient coordinate descent
algorithm following by discussion on some practical issues. In Section 4, we establish the
error bound and prediction error of the proposed method. In particular, our theoretical
results explain why a small number of samples (i.e., nr) from the reference panel can be
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good enough for effect size estimation and risk prediction. In Section 5, we show the
results from both simulation studies and real data analysis.
2 The REMI model
2.1 The REMI model
For the linear regression model (1), if the individual-level data (y,X) is available, a basic
approach for estimating β∗ in high-dimensional settings is the Lasso [31]. The Lasso
estimator is given by
β̂ = arg min
β
1
n
‖y −Xβ‖2 + λ‖β‖1, (2)
where ‖ · ‖1 is the `1 norm and λ ≥ 0 is a regularization parameter. In our problem,
however, the individual-level data {X,y} is not accessible. Hence, direct application of
the Lasso is not feasible here. We note that several other important penalized methods
have been proposed, including SCAD [10] and MCP [44]. We will focus on the Lasso
penalty below, although our proposed approach can also be based on the other penalties.
We now describe our proposed REMI model with the Lasso penalty. Rewrite (2) as
β̂ = arg min
β
1
n
(βTXTXβ − 2βTXTy + yTy) + λ‖β‖1
= arg min
β
βTXTXβ/n− 2βTXTy/n+ λ‖β‖1, (3)
where the second term only involves the inner product of the optimization variable β
and marginal information, say, y˜ = XTy/n, which we assume is available. The difficulty
comes from the first term, where XTX/n is unknown since X is not observed. Motivated
by the application in GWAS, we assume that there exists a reference nr × p data matrix
Xr, where the rows of Xr are i.i.d. and have the same distribution with covariance matrix
Σ as the rows of X. Therefore, both Σ̂ = XTX/n and Σ̂r = X
T
r Xr/nr can be viewed as
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estimators of Σ. So we propose to solve the following optimization problem to estimate
β∗:
β̂
c
= arg min
β
βTXTr Xrβ/nr − 2βT y˜ + λ‖β‖1, (4)
where β̂
c
denotes the estimator using the reference covariance matrix. Clearly, the above
model (4) only uses the marginal correlation between X and y, with the covariance matrix
estimated by an external reference panel Xr.
2.2 REMI in GWAS
In the context of GWAS, the available marginal information may not be y˜ = XTy/n but
summary statistics {β̂mj , sˆ2j}j=1,...,p from univariate linear regression:
β̂mj = (X
T
j Xj)
−1XTj y, sˆ
2
j = (nX
T
j Xj)
−1(y −Xjβ̂mj )T (y −Xjβ̂mj ),
where superscript m is used to denote marginal information. β̂mj and sˆ
2
j are the estimated
effect size and its variance for SNP j, respectively. Due to the polygenicity of many com-
plex phenotypes, the standard errors can be well approximated by sˆj ≈
√
(nXTj Xj)
−1yTy
(Zhu and Stephens 2016). Let β̂
m
= [β̂m1 , . . . , β̂
m
p ]
T , sˆ2 = [sˆ21, ..., sˆ
2
p]
T be the vectors col-
lecting estimated effect sizes and estimated variance, respectively, and Ŝ be a p × p di-
agonal matrix with sˆj being its j-th diagonal element. Further, we introduce a p × p
diagonal matrix D̂ = diag(dˆj) with its j-th diagonal element being the sample stan-
dard deviation of Xj, i.e., dˆj =
√
XTj Xj
n
, and correlation matrix R̂ = [rˆjk] ∈ Rp×p with
rˆjk =
XTj Xk
(XTj Xj)
1/2(XTkXk)
1/2 . Noticing that dˆ
2
j β̂
m
j = X
T
j y/n and n
2dˆ2j sˆ
2
j ≈ yTy, the REMI
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formulation (3) becomes
β̂ = arg min
β
βTXTXβ/n− 2βTXTy/n+ λ‖β‖1,
= arg min
β
βT D̂R̂D̂β − 2βT D̂2β̂m + λ‖β‖1,
≈ arg min
β
yTy
n2
βT Ŝ−1R̂Ŝ−1β − 2y
Ty
n2
βT Ŝ−2β̂
m
+ λ‖β‖1,
= arg min
β
βT Ŝ−1R̂Ŝ−1β − 2βT Ŝ−2β̂m + λ˜‖β‖1,
where λ˜ = n
2
yTy
λ and the approximation holds in the case of polygenicity. Because λ˜ is
a tuning parameter that scales λ with a constant factor ( n
2
yTy
), we slightly abuse λ for λ˜
and propose to solve the following optimization problem
β̂
r
= arg min
β
L(β) + λ‖β‖1, (5)
where L(β) = βT Ŝ−1R̂Ŝ−1β−2βT Ŝ−2β̂m, and β̂r denotes the estimates using correlation
information. Similar to REMI (4) in which covariance matrix Σ̂ = XTX/n needs to be
estimated, here correlation matrix R̂ needs to be estimated by samples from the reference
panel Xr. We refer (4) as REMI-C and (5) as the REMI-R, respectively.
3 Algorithm and Practical Issues
3.1 Algorithm
Here we adopt the widely used coordinate descent algorithm, which updates one parameter
at a time, say β̂cj , keeping all other parameters fixed at their current values. Thus the
sub-problem for parameter β̂cj can be written as
β̂cj (λ) = arg min
βj
σ̂jjβ
2
j − 2
(
y˜j −
∑
k 6=j
β̂ckσ̂jk
)
βj + λ|βj|, (6)
where σ̂jk is an element in Σ̂r = [σ̂jk] ∈ Rp×p. An efficient path algorithm can be developed
based on the warm start and some other tricks as described in [11]. In particular, we
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generate a sequence of λ = (λ1, . . . , λD) equally spaced in logarithm with λ1 = λmax and
λD = τλmax, where λmax is the minimum λ that shrinks all parameters to zero and τ is
usually set to 0.05. For each λ, we use the solution of (4) from the last λ value as warm
start. The path algorithm is described in Algorithm 1.
Algorithm 1: Path algorithm to solve REMI-C (4) with a sequence of λ =
(λ1, . . . , λD)
Output : Solution path for β̂
c
(λ).
for l = 1, 2, . . . , D do
Initialize β̂
c
(λl) = β̂
c
(λl−1), if l > 1; β̂(λl) = 0, if l = 1
repeat
for j = 1, 2, . . . , p do
ηj = y˜j −
∑
k 6=j β̂
c
k(λ)σ̂jk
β̂cj (λ)← S(ηj, λ/2)/σ̂jj
end
until Convergence;
end
Similar to REMI-C, an efficient coordinate descent algorithm can developed for solving
REMI-R (5). The efficient path algorithm is given in Algorithm 2.
Algorithm 2: Path algorithm to solve REMI-R (5) with a sequence of λ =
(λ1, . . . , λD)
Output : Solution path β̂
r
(λ).
for l = 1, 2, . . . , D do
Initialize β̂
r
(λl) = β̂
r
(λl−1), if l > 1; β̂
r
(λl) = 0, if l = 1
repeat
for j = 1, 2, . . . , p do
ηj =
β̂j
m
sˆ2j
− 1
sˆj
∑
k 6=j
β̂k
r
rˆjk
sˆk
β̂j
r
(λ)← S(ηj, λ/2)× sˆ2j
end
until Convergence;
end
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3.2 Reference panel
In REMI-R model (5), it involves the cohort-based estimated correlation matrix. Based
on the nature of the correlation patterns of the SNPs, R can be approximated by a
block diagonal matrix. Specifically, we first partition the whole genome into L blocks
(L = 1, 703 for European ancestry and L = 1, 445 for Asian ancestry, respectively [1]).
Then we calculate empirical correlation matrix R̂emp for each LD-block. To ensure a stable
numerical result, we apply a simple shrinkage estimator to obtain R̂r = κR̂emp + (1− κ)I
within each block [30], where we used κ = 0.9 as default (the estimate of β∗ is insensitive
to κ [25]). Thus, similar to [49], REMIs and its individual-level-data counterpart will
produce approximately the same inferential results within a region. After plugging Ŝ and
R̂r in (5), we can use the coordinate-descent algorithm to obtain β̂
r
(λ) (Algorithm 2).
3.3 Choice of regularization parameter λ
The REMIs have one regularization parameter λ. Here we briefly show how to choose
this parameter for REMI-R and it is straightforward to develop the same strategy for
REMI-C. Similarly to the Lasso solver [11], we generate a sequence of λ from λmax to
τλmax, where λmax is the minimum value of λ that shrinks all parameters to zero and τ is
pre-specified with the default value at 0.05. Note that λmax = max
{
2βˆmj /sˆ
2
j
}
j=1,...,p
. We
search for optimal value λ value using BIC,
BIC(λl) = L(β̂
r
(λl)) + log(n)df(λl). (7)
Zou et al. [50] showed that the number of nonzero coefficients is an unbiased estimate for
the degrees of freedom of Lasso. We choose df(λl) to be the number of nonzero coefficients
given λl. To make fair comparison of REMIs with Lasso, we also use BIC to select the
regularization parameter when individual-level-data is accessible.
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4 Theoretical properties
In this section, we give nonasymptotic bounds on the estimation error ‖β∗A− β̂
c‖ and the
prediction error ‖Xnewβ∗A −Xnewβ̂
c‖2/nnew, where A denotes index of significant entries
of β∗ and β∗A denote the vector supported on A.
Since in real applications of genetic data the underlying signal is not exactly sparse
but with many small components. Here, we assume that the target β∗ is weak sparse, i.e.,
in addition to some significant components indexed by A, there may be many nonzero
entries in β∗ with very small magnitude, as indexed by I = Ac. Let β∗I be the vector
supported on I. It is reasonable to assume that
s = |A| ≤ n, ‖β∗I‖∞ ≤ 2σ
√
log p
n
, (8)
since the signal whose magnitude smaller than this order is undetectable. Then
y˜ = Σ̂β∗ + ˜ = Σ̂β∗A + Σ̂β
∗
I + ˜, (9)
where, ˜ = XT/n. Let C1 ≥ ‖diag(Σ)‖∞, C2 ≥ maxj=1,...p{‖Σj‖1}, C3 ≥ ‖β∗A‖1, C4 ≥
‖β∗I‖1. Recall the restrict eigenvalue [3] of Σ̂r is defined as
φΣ̂r = min06=v∈CA,3
vT Σ̂rv
‖v‖22
,
where
CA,3 = {v ∈ Rp : ‖vI‖1 ≤ 3‖vA‖1}.
Theorem 1 Assume the rows of X and Xr are i.i.d sub-Gaussian samples drawn from
population with mean 0 and covariance matrix Σ, and Σ̂r satisfying restricted eigenvalue
condition with φΣ̂r ≥ φ0 > 0, and the noise vector  is mean zero sub-Gaussian with
noise level σ, and n ≥ 4C log p, nr ≥ 4C log p. Take λ ≥ 2λ0 = 4(C1(C3+C4)√C
√
log p
n
+
C1+
√
CC2√
C
σ
√
log p
n
+ C1C3√
C
√
log p
nr
).
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(i) With probability at least 1− 3/p2 − 1/p3 we have
‖β̂c − β∗A‖ ≤
6
φ0
(
C1(C3 + C4)√
C
√
s log p
n
+
C1 +
√
CC2√
C
σ
√
s log p
n
+
C1C3√
C
√
s log p
nr
).
(ii) Suppose we observe Xnew ∈ Rnnew×p, whose rows are sampled from the same
distribution as that of X’s. Then with probability at least 1− 3/p2 − 1/p3, the prediction
error satisfies
‖Xnew(β̂
c − β∗A)‖22/nnew ≤ O((σ
√
s log p
n
+
√
s log p
nr
)2)(1 + s2(
√
log p
nr
+
√
log p
nnew
)).
Remark 2 The assumption that Xr are i.i.d sub-Gaussian samples drawn from popu-
lation with mean 0 and covariance matrix Σ implies the restricted eigenvalue condition
φΣ̂r ≥ φ0 holds for some positive φ0 with high probability as long as nr ≥ O(s log p)
[32, 34, 20]. As shown in Theorem 1, with the help of reference panel, we can also get an
accurate estimator by (4) even if we only have marginal information in high-dimension
setting as long as n ≥ O(s log p) and nr ≥ O(s log p). Furthermore, the estimation
error of REMI model (4) achieve the minimax optimal rate as that of the Lasso [28]
if the number of samples of reference penal nr is at the same order of the number of
individual-level samples n. Moreover if the magnitude of the significant entries larger
than O(σ
√
s log p
n
+
√
s log p
nr
), the estimated support supp(β̂
c
) coincide with the true sig-
nificant set A.
5 Numerical Studies
5.1 Simulation studies
In simulation studies, we compare REMI-C (4), REMI-R (5) and Lasso using individual-
level data. To avoid unrealistic LD pattern in simulation, we used the genotype data
X from the GERA data set [17]. The GERA data set provided 657,184 genotyped
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SNPs for 62,313 European individuals. We performed strict quality control on data us-
ing PLINK [27]. We excluded SNPs with a minor allele frequency less than 1%, having
missing values in more than 1% of the individuals or with a Hardy-Weinberg equilibrium
p-value below 0.0001. Moreover, we removed one member of pairs with genetic relatedness
larger than 0.05. Finally, there remained 53,940 samples for 550,482 SNPs.
As individual-level-based analyses often suffer from limited sample sizes due to the
restricted access of individual-level data, summary-level-based analyses may have advan-
tages because the sample sizes are often much larger. To simulate this situation, we
prefixed the sample size for individual-level-based analyses at nind = 3, 000. Specifically
we randomly selected nind samples from 53,940 individuals in the GERA data set to form
the genotype matrix X ∈ Rnind×p, where p = 19, 865 was the total number of the geno-
typed SNP on chromosomes 16, 17 and 18. Then the phenotype vector y was generated
as y = Xβ∗+, where  ∼ N (0, σ2 ) and the heritability (h2 = Var(Xβ)Var(Xβ∗)+σ2 ) was controlled
at 0.2, 0.3, 0.4 and 0.5. Here β∗ was the vector of true effect size with sparsity α, i.e.,
α× p entries in β∗ were nonzero and they were sampled from N (0, 1). In our simulation
study, we varied α in {0.001, 0.003, 0.005, 0.007, 0.01, 0.02}. With {X,y} at hand, the
standard Lasso can be applied, serving as a reference of individual-level data analysis.
To generate summary-level data, we varied sample size n from 3,000 to 50,000. We
generated individual-level data as we described above and then we ran simple linear
regression on {Xj,y}, j = 1, . . . , p to obtain {β̂
(m)
, sˆ2}. After that, we pretended that we
did not have individual-level data {X,y} and then only used XTy and {β̂(m), sˆ2} as the
input for REMI-C and REMI-R, respectively. We used 379 European samples from the
1000 Genome Project data as the reference panel to estimate covariance matrix (REMI-C)
or correlation matrix (REMI-R), as detailed in Section 3.2. For each replication, we held
out 200 independent samples to evaluate prediction accuracy. In total, we summarized
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our results based on 50 replications for each setting.
We compared the performance of REMI-C, REMI-R and the Lasso using individual-
level data in terms of variable selection and prediction. Specifically, we used partial
area under the receiver operating characteristic (ROC) curve (partial AUC) for variable
selection performance and the Pearson’s correlation coefficient between predicted and
observed phenotypes for prediction performance. The results of this simulation study are
shown in Figure 1 and Figure 2. First, we can observe that the difference between REMI-
C and REMI-R is nearly invisible. This justifies the approximation made in REMI-R.
Second, when the sample size (n = 3,000 or 5,000) in summary-level data is similar to
that of individual-level data (nind = 3, 000), the performance of variable selection and
prediction for REMIs (both REMI-C and REMI-R) is similar to that of Lasso. Third,
REMIs gradually outperform the Lasso as the sample size increases from 5,000 to 50,000,
for both variable selection and prediction. This clearly indicates that REMIs can have
big advantages over the Lasso when the sample sizes of summary-level data become much
larger.
5.2 Real data analysis
To demonstrate the utility of REMIs, we first compared Lasso and REMIs based on the
GWAS data set from the Northern Finland Birth Cohorts program (NFBC1966) [29]. The
NFBC1966 data set contains information for 5,402 individuals with a selected list of phe-
notypic data related to cardiovascular disease including high-density lipoprotein (HDL),
low-density lipoprotein (LDL), total cholesterol (TC), triglycerides (TG), C-reactive pro-
tein (CRP), glucose, insulin, body mass index (BMI), systolic (SysBP) and diastolic
(DiaBP) blood pressure. For each individual, 364,590 SNPs have been genotyped. We
performed strict quality control on data using PLINK [27]. We first excluded individuals
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having discrepancies between reported sex and sex determined from the X chromosome.
We also excluded SNPs with a minor allele frequency less than 1%, having missing val-
ues in more than 1% of the individuals or with a Hardy-Weinberg equilibrium p-value
below 0.0001. In particular, we selected well-imputed variants from HapMap 3 refer-
ence panel [9]. After the strict quality control, 5,123 individuals with 310,975 SNPs in
NFBC1966 were remaining for the further analysis. As we have the individual-level data,
it is possible to run REMI-C, REMI-R and Lasso for all these traits. The solution paths
using Lasso, REMI-R, and REMI-C for the ten metabolic traits in NFBC1966 data set
are presented in Figures 3. The dotted vertical bars in these two figures indicate the
corresponding selected tuning parameters based on BIC. One can see that the differences
among solution paths for the Lasso using individual-level data, REMI-C and REMI-R us-
ing summary statistics are very minor, which is consistent with results from our simulation
studies in Section 5.1.
In the released GWAS summary-level data sets, it is often the case that {β̂(m), sˆ2}
rather than the inner product XTy is made available. Therefore, we applied REMI-R
to analyze summary statistics for ten GWASs of complex phenotypes. The source of the
GWASs is given in Table 1. Because the individuals of summary-level data sets were
all from European ancestry, we used 379 European-ancestry samples in 1000 Genome
Project [8] as a reference panel to estimate correlation matrix. Due to the quality of
SNPs in the summary statistics, we restricted our analysis to a set of common and well-
imputed variants from the HapMap 3 reference panel [9], which included 1,197,724 SNPs
in total. Figure 4 shows the Manhattan plots of summary statistics for height (Ht)
including − log10(p-value), |β̂
m| and |β̂r|. The Manhattan plots of the absolute effect
sizes from REMI-R for all other nine traits are shown in Figure 5.
Besides the effect size estimation, we evaluated prediction performance using 5,123
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samples from the NFBC1966 [29]. To make a fair comparison with Lasso, we first split
all 5,123 samples into ten folds. On the one hand, we applied REMI-R on the summary
statistics for these lipid traits listed in Table 1. Again, we used 379 European-ancestry
samples from the 1000 Genome Project as a reference panel. For each of 10 folds in
NFBC1966 data set, we calculated the predicted phenotypic values and evaluated the
Pearson’s correlation coefficients between the predicted phenotypic values and the ob-
served ones. On the other hand, we fitted the Lasso on the individual-level NFBC1966
data using the same ten-fold data for cross-validation. Specifically, we randomly selected
nine folds of individual-level data as the training set to fit the Lasso, and evaluated pre-
diction accuracy of the fitted model using the remaining one fold. Note that we used the
same remaining fold to evaluate the prediction accuracy of the fitted REMI-R model. The
prediction performance for REMI-R and Lasso is shown in Figure 6. Clearly, the predic-
tion performance of REMI-R outperforms the standard Lasso as the sample size in the
summary statistics for these lipid traits are around 100,000 but the individual-level data
contains only 5,123×9/10 samples. These real data results indicate the great advantage
of REMI over the Lasso for risk prediction.
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Figure 1: The comparison of variable selection performance of REMIs (REMI-R and
REMI-C) for summary-statistics data with Lasso for individual-level data with sample
size 3000. The sample size used to produce summary statistics was varied and denoted as
n ∈ {3, 000, 5, 000, 10, 000, 20, 000, 50, 000}. We used partial AUC to measure the variable
selection performance.
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Figure 2: Prediction accuracy of REMIs with summary-level data and the Lasso for
individual-level data of sample size 3,000. The sample size used to simulate summary
statistics was varied n ∈ {3, 000, 5, 000, 10, 000, 20, 000, 50, 000}. Prediction accuracy is
measured by the Pearson’s correlation coefficient between predicted and observed pheno-
types.
19
Figure 3: Solution paths of Lasso, REMI-R, and REMI-C for HDL, LDL, TG, CRP TC,
BMI, SysBP, DiaBP, Insulin and Glucose using the NFBC1966 data sets.
20
Figure 4: Manhattan plots of analysis result of human height for: -log10p-value, |β̂
m| from
marginal analysis and |β̂r| from REMI-R.
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Figure 5: Manhattan plots of |β̂r| from REMI-R for HDL, LDL, TC, TG, CKD-overall,
T2D, CARDI, AD and RA.
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Figure 6: Prediction accuracy (measured by the Pearson’s correlation coefficients) of
REMI-R and the Lasso for HDL, LDL, TC and TG in the NFBC1966 data sets, where
REMI-R was fitted using independent summary-level data and the Lasso was fitted using
the individual-level data from NFBC1966. Their prediction accuracies were evaluated on
1/10 of the NFBC1966 data set holded out for testing.
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Table 1: GWAS data sets in our experiment
ID YEAR Traits Sample Size SNPs Link
AD 2013 Alzheimer Disorder 54162 1149751 http://www.pasteur-lille.fr/en/recherche/u744/igap/igap_download.php
CARDI 2015 Coronary Artery Disease 817857 1197724 http://www.cardiogramplusc4d.org/data-downloads/
CKD-overall 2015 eGFRcrea in overall population 133715 984086 https://www.nhlbi.nih.gov/research/intramural/researchers/ckdgen
HDL 2013 High-Density-Lipid cholesterol 94272 992986 http://csg.sph.umich.edu//abecasis/public/lipids2013/
Ht 2014 Height 252778 827344 http://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files
LDL 2013 Low-Density-Lipid cholesterol 89851 990583 http://csg.sph.umich.edu//abecasis/public/lipids2013/
TC 2013 Total Cholesterol 94556 992889 http://csg.sph.umich.edu//abecasis/public/lipids2013/
TG 2013 Triglycerides 90974 990915 http://csg.sph.umich.edu//abecasis/public/lipids2013/
RA 2010 Rheumatoid Arthritis 25708 989551 http://www.broadinstitute.org/ftp/pub/rheumatoid_arthritis/Stahl_etal_2010NG/
T2D 2008 Type 2 Diabetes 63390 1061515 http://diagram-consortium.org/downloads.html
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6 Discussion
In this study, we proposed a novel approach for high-dimensional regression analysis
when only marginal regression information and an external reference panel data set are
available. Our work is motivated from combining information from multiple GWAS. To
date, a large number of GWAS have been conducted to find genetic factors associated
with complex traits. Due to the need for privacy protection and issues in data-sharing of
individual-level data, it is important to be able to effectively make full use of the summary
statistics from separate studies. In contrast to the limited sample size in individual-level
data based GWAS analysis, a prominent feature of summary-level data analysis is that
it can effectively make use of multiple data sets, which leads to a much larger combined
sample size.
Under mild conditions, we prove that the REMI estimator (4) based on the marginal
information and the reference penal achieves the minimax optimal rate estimation error
under reasonable conditions. In particular, the requirement on the size of the reference
panel data is quite mild, it is only in the order of the logarithm of the model dimension.
Our theoretical result successfully explains why a relatively small reference sample can
be good enough for accurate estimation and prediction in real applications. We have
conducted comprehensive simulations and real data analysis to demonstrate the utility of
REMI. The experimental results show that the performance of REMI can be very similar
to the Lasso when the sample sizes of summary-level data and individual-level data are
the same. In genetic analysis, summary-level data sets are much easier to access and their
sample sizes are often orders of magnitude larger than that of individual-level data sets.
Consequently, REMI can be superior to the existing methods requiring complete data by
taking advantages of the larger sample sizes, as demonstrated in our real data example.
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Appendix
We recall some simple properties of subgaussian and subexponential random variables.
Lemma 3 ( Lemma 2.7.7 of [33] and Remark 5.18 of [34].) Let ξ1, ξ2 be sub-Gaussian
random variables with noise level ‖ξ1‖ψ2 ≤ σξ1 and ‖ξ2‖ψ2 ≤ σξ2 , respectively. Then both
ξ1ξ2 and ξ1ξ2 − E[ξ1ξ2] are sub-exponential random variables, and there exist an absolute
constant C > 0 such that ‖ξ1ξ2 − E[ξ1ξ2]‖ψ1 ≤ Cσξ1σξ2 .
We state the Bernstein-type inequality for the sum of independent and mean 0 sub-
exponential random random variables
Lemma 4 (Corollary 5.17 of [34]) Let ξ1, ..., ξm be independent centered sub-exponential
random variables. Then for every t > 0 one has
P[|
m∑
i=1
ξi|/m ≥ t] ≤ 2 exp(−C min{ t
2
K2
,
t
K
}m),
where, C is a absolute constant and K = maxi=1,..m{‖ξi‖ψ1}.
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Lemma 5 Suppose the rows of X and Xr are i.i.d sub-Gaussian samples drawn from
population with mean 0 and covariance matrix Σ. Then, with probability at least 1−1/p2,
we have
‖Σ̂−Σ‖∞ ≤ 2C1√
C
√
log p
n
,
and
‖Σ̂r −Σ‖∞ ≤ 2C1√
C
√
log p
nr
,
as long as n > 4
C
log p and nr >
4
C
log p.
Proof of Lemma 5. Since the proof of these two results are similar, we give one of
them. Let xi be the i−th row of X, i = 1, ...n, and (xi)j denote the j−th entry of xi.
Define Gij,k := (xi)j(xi)k − E[(xi)j(xi)k] ∈ R1, i = 1, ..., n, j = 1, ..., p, k = 1, .., p, which is
sub-exponential with ‖Gij,k‖ψ1 ≤ C1 by Lemma 3. Therefore,
P[‖Σ̂−Σ‖∞ ≥ t] = P[‖
n∑
i=1
(xTi xi − E[xTi xi])/n‖∞ ≥ t]
= P[
p,p⋃
j=1,k=1
|
n∑
i=1
Gij,k/n| ≥ t]
≤
p,p∑
j=1,k=1
P[|
n∑
i=1
Gij,k|/n ≥ t]
≤ p2 exp(−C min{ t
2
C21
,
t
C1
}n) (10)
≤ p2 exp(−C t
2
C21
n)
where the first inequality is due to union bound, and the second one follows from Lemma
4 and the last inequality is because of restricting t ≤ C1. Then Lemma 5 follows from
setting t = 2C1√
C
√
log p
n
and the assumption that n > 4
C
log p. 
The following Lemma 6 - Lemma 8 are building blocks for proving Theorem 1.
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Lemma 6 Under the same assumption as Lemma 5, we have
‖(Σ̂− Σ̂r)β∗A‖∞ ≤
2C1C3√
C
(
√
log p
n
+
√
log p
nr
),
holds with probability at least 1− 2/p2.
Proof of Lemma 6.
‖(Σ̂− Σ̂r)β∗A‖∞ ≤ ‖(Σ̂−Σ)β∗A‖∞ + ‖(Σ− Σ̂r)β∗A‖∞
≤ ‖Σ̂−Σ‖∞‖β∗A‖1 + ‖Σ− Σ̂r‖∞‖β∗A‖1
≤ 2C1C3√
C
√
log p
n
+
2C1C3√
C
√
log p
nr
,
where the first inequality is due to triangle inequality, and the second inequality follows
from Cauchy-Schwartz inequality, and the last one holds with probability larger than
1− 2/p2 due to Lemma 5. This finishes the proof of Lemma 6. 
Lemma 7 Suppose the rows of X are i.i.d sub-Gaussian samples drawn from population
with mean 0 and covariance matrix Σ, and the entries of noise  are i.i.d centered sub-
Gaussian with noise level σ. With probability at least 1− 1/p3, we have
‖˜‖∞ < 2σ C1√
C
√
log p
n
,
provided that n ≥ 4 log p
C
.
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Proof of Lemma 7. We have,
P[‖˜‖∞ < t] = P[‖XT/n‖∞ < t]
= 1− P[‖XT/n‖∞ ≥ t]
= 1− P[
p⋃
j=1
|XTj /n| ≥ t]
≥ 1−
p∑
j=1
P[|
n∑
i=1
(Xj)ii|/n ≥ t]
≥ 1− p exp(−C min{ t
2
C21σ
2

,
t
C1σ
}n)
≥ 1− p exp(−C t
2
C21σ
2

n)
≥ 1− 1/p3, (11)
the first inequality is due to union bound, and the second one follows from Lemma 3 and
Lemma 4, where we use ‖(Xj)ii − E[(Xj)ii]‖ψ1 ≤ CσC1, and the last two inequality
follows from by setting t = 2σC1
√
log p
Cn
and the assumption that n > 4
C
log p, i.e., with
probability at least 1− 1/p3, we have
‖˜‖∞ ≤ 2σC1
√
log p
Cn
.

Lemma 8 Under the same assumption as Lemma 7, we have,
‖Σ̂β∗I‖∞ ≤
2C1C4√
C
√
log p
n
+ 2C2σ
√
log p
n
.
with probability larger than 1− 1/p2.
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Proof of Lemma 8.
‖Σ̂β∗I‖∞ ≤ ‖Σβ∗I‖∞ + ‖(Σ̂−Σ)β∗I‖∞
≤ max
j=1,...p
{‖Σj‖1}‖β∗I‖∞ + ‖Σ̂−Σ‖∞‖β∗I‖1
≤ 2C2σ
√
log p
n
+
2C1C4√
C
√
log p
n
,
where first inequality is due to triangle inequality, and the second one follows from Cauchy-
Schwartz inequality, the third inequality holds with probability larger than 1 − 1/p2 by
using (8) and Lemma 5. This completes the proof of Lemma 8. 
Now we are ready to prove Theorem 1.
Proof of Theorem 1. (i). Let ∆ = β̂
c − β∗A. Define the event
E = {2‖(Σ̂− Σ̂r)β∗A + Σ̂β∗I + ˜‖∞ ≤ λ0}.
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The optimality of β̂
c
implies that
〈β̂c, Σ̂rβ̂
c〉 − 2〈y˜, β̂c〉+ λ‖β̂c‖1 ≤ 〈β∗A, β̂
c
β∗A〉 − 2〈y˜,β∗A〉+ λ‖β∗A‖1,
⇓ (eq1)
〈β̂c − β∗A, Σ̂r(β̂
c − β∗A)〉+ 2〈β∗A, Σ̂r(β̂
c − β∗A)〉+ λ(‖β̂
c
A‖1 + ‖β̂
c
I‖1) ≤ 2〈y˜, β̂
c − β∗A〉+ λ‖β∗A‖,
⇓ (eq2)
〈∆, Σ̂r∆〉+ λ‖∆I‖1 ≤ 2〈y˜,∆〉 − 2〈Σ̂rβ∗A,∆〉+ λ‖β∗A‖ − λ‖β̂
c
A‖1,
⇓ (eq3)
〈∆, Σ̂r∆〉+ λ‖∆I‖1 ≤ 2〈(Σ̂− Σ̂r)β∗A + Σ̂β∗I + ˜,∆〉+ λ‖∆A‖,
⇓ (eq4)
〈∆, Σ̂r∆〉+ λ‖∆I‖1 ≤ 2‖(Σ̂− Σ̂r)β∗A + Σ̂β∗I + ˜‖∞‖∆‖1 + λ‖∆A‖,
⇓ (eq5)
〈∆, Σ̂r∆〉+ λ‖∆I‖1 ≤ λ
2
(‖∆A‖1 + ‖∆I‖1) + λ‖∆A‖,
⇓ (eq6)
〈∆, Σ̂r∆〉+ λ
2
‖∆I‖1 ≤ 3
2
λ‖∆A‖1, (12)
where, (eq1) and (eq2) and (eq6) are due to some algebra, and (eq3) follows from (9),
and (eq4) uses Cauchy-Schwartz inequality, and (eq5) holds by conditioning E and the
assumption λ0 ≤ λ/2. It follow from (12) that
∆ ∈ CA,3. (13)
Then, by the restricted eigenvalue condition on Σ̂r and (12) we deduce,
φ0‖∆‖22 ≤ 〈∆, Σ̂r∆〉 ≤
3
2
λ‖∆A‖1 ≤ 3
2
√
sλ‖∆‖2,
i.e.,
‖∆‖2 ≤ 3
2φ0
√
sλ ≤ 6
φ0
(
C1(C3 + C4)√
C
√
s log p
n
+
C1 +
√
CC2√
C
σ
√
s log p
n
+
C1C3√
C
√
s log p
nr
).
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The above induction is conditioning on E . We need give a lower bound on P[E ]. Indeed,
2‖(Σ̂− Σ̂r)β∗A + Σ̂β∗I + ˜‖∞ ≤ 2‖(Σ̂− Σ̂r)β∗A‖∞ + 2‖Σ̂β∗I‖∞ + 2‖˜‖∞
Then, it follows Lemma 6 and Lemma 7 and Lemma 8 that P[E ] ≥ 1− 3/p2 − 1/p3. This
completes the first part of proof of Theorem 1.
(ii). Let Σ̂new = X
T
newXnew/nnew. Then,
‖Xnew(β̂
c − β∗A)‖22/nnew = 〈Σ̂new(β̂
c − β∗A), β̂
c − β∗A〉
= 〈∆, Σ̂r∆〉+ 〈∆, (Σ̂new − Σ̂r)∆〉
≤ 3
2
λ‖∆A‖1 + ‖∆‖21‖Σ̂new − Σ̂r‖∞
≤ 3
2
λ‖∆A‖1 + ‖∆‖21
2C1√
C
(
√
log p
nr
+
√
log p
nnew
)
≤ O(σ
√
s log p
n
+
√
s log p
nr
)‖∆A‖2 +O(
√
log p
nr
+
√
log p
nnew
)s2‖∆A‖22
≤ O((σ
√
s log p
n
+
√
s log p
nr
)2)(1 + s2(
√
log p
nr
+
√
log p
nnew
))
where, the first inequality uses (12) and Cauchy-Schwartz inequality, and the second
one is due to Lemma 5, and the third inequality follow from (13) and Cauchy-Schwartz
inequality, the fourth inequality uses Theorem 1. This completes the second part of proof
of Theorem 1. 
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